Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2001;32:1181-1184

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niskakangas, T.
Right arrow Articles by Karhunen, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niskakangas, T.
Right arrow Articles by Karhunen, P. J.
Related Collections
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage
Right arrow Genetics of Stroke

(Stroke. 2001;32:1181.)
© 2001 American Heart Association, Inc.


Original Contributions

Association of Apolipoprotein E Polymorphism With Outcome After Aneurysmal Subarachnoid Hemorrhage

A Preliminary Study

Tero Niskakangas, MD; Juha Öhman, MD, PhD; Mika Niemelä, MD, PhD; Erkki Ilveskoski, MD; Tarja A. Kunnas, MSc Pekka J. Karhunen, MD, PhD

From the Department of Neurosurgery, Helsinki University Central Hospital (T.N., J.Ö., M.N.), Helsinki, Finland; the Department of Forensic Medicine, University of Tampere and Tampere University Hospital (T.N., E.I., T.A.K., P.J.K.), Tampere, Finland; and the Department of Clinical Pathology and Forensic Medicine (P.J.K.), University of Kuopio, Kuopio, Finland.

Correspondence to Tero Niskakangas, Helsinki University Central Hospital, Department of Neurosurgery, Topeliuksenkatu 5, FIN- 00260 Helsinki, Finland. E-mail tero.niskakangas{at}hus.fi

Background and Purpose—Variation in the outcome after aneurysmal subarachnoid hemorrhage (SAH) is not fully explained by known prognostic factors. APOE genotype is the most important genetic determinant of susceptibility to Alzheimer’s disease, and it is also shown to be associated with the outcome after traumatic brain injury. We studied the association of apolipoprotein E polymorphism with the outcome after aneurysmal SAH.

Methods—A total of 160 consecutive patients were admitted after SAH to a neurosurgical unit. The clinical assessment after the SAH was performed with the Hunt and Hess grading scale. The severity of the bleeding as visualized on CT was assessed by Fisher’s grading system. Outcome was assessed with the Glasgow Outcome Scale. APOE genotypes were determined by polymerase chain reaction–restriction fragment length polymorphism.

Results—126 patients had aneurysmatic SAH, and detailed information on outcome and APOE genotype was available for 108 patients (86%). Sixteen (40%) of 40 patients with APOE {epsilon}4 had an unfavorable outcome compared with 13 (19%) of 68 without the APOE {epsilon}4 allele (OR 2.8, 95% CI 1.18 to 6.77). Association was more significant after adjustment for age, rebleeding, clinical status on admission, and CT scan findings (OR 7.1, 95% CI 1.9 to 26.3; P=0.0035).

Conclusions—Our findings show a significant genetic association of APOE polymorphism with outcome after spontaneous aneurysmal SAH. Genetic factors thus seem to explain a part of individual differences in the recovery of SAH.


Key Words: apolipoproteins • genetics • outcome • subarachnoid hemorrhage




This article has been cited by other articles:


Home page
Biol Res NursHome page
M. J. Gallek, Y. P. Conley, P. R. Sherwood, M. B. Horowitz, A. Kassam, and S. A. Alexander
APOE Genotype and Functional Outcome Following Aneurysmal Subarachnoid Hemorrhage
Biol Res Nurs, January 1, 2009; 10(3): 205 - 212.
[Abstract] [PDF]


Home page
Biol Res NursHome page
S. A. Alexander, M. E. Kerr, J. Balzer, M. Horowitz, A. Kassam, Y. Kim, L. Hoffman, and Y. P. Conley
Cerebrospinal Fluid Apolipoprotein E, Calcium and Cerebral Vasospasm after Subarachnoid Hemorrhage
Biol Res Nurs, October 1, 2008; 10(2): 102 - 112.
[Abstract] [PDF]


Home page
NeurologyHome page
L. A. Lanterna, Y. Ruigrok, S. Alexander, J. Tang, F. Biroli, L. T. Dunn, and W. S. Poon
Meta-analysis of APOE genotype and subarachnoid hemorrhage: Clinical outcome and delayed ischemia
Neurology, August 21, 2007; 69(8): 766 - 775.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. J. Rosengart, K. E. Schultheiss, J. Tolentino, and R. L. Macdonald
Prognostic Factors for Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage
Stroke, August 1, 2007; 38(8): 2315 - 2321.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
N A Martinez-Gonzalez and C L M Sudlow
Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage
J. Neurol. Neurosurg. Psychiatry, December 1, 2006; 77(12): 1329 - 1335.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C Smith, D I Graham, L S Murray, J Stewart, and J A R Nicoll
Association of APOE e4 and cerebrovascular pathology in traumatic brain injury.
J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 363 - 366.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
G. M. Teasdale, G. D. Murray, and J. A. R. Nicoll
The association between APOE {varepsilon}4, age and outcome after head injury: a prospective cohort study
Brain, November 1, 2005; 128(11): 2556 - 2561.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. A. Lanterna, M. Rigoldi, G. Tredici, F. Biroli, C. Cesana, S. M. Gaini, and L. Dalpra
APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage
Neurology, April 12, 2005; 64(7): 1238 - 1244.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P D Leclercq, L S Murray, C Smith, D I Graham, J A R Nicoll, and S M Gentleman
Cerebral amyloid angiopathy in traumatic brain injury: association with apolipoprotein E genotype
J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 229 - 233.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Singhal, S. Bevan, T. Barrick, P. Rich, and H. S. Markus
The influence of genetic and cardiovascular risk factors on the CADASIL phenotype
Brain, September 1, 2004; 127(9): 2031 - 2038.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. L. Macdonald
Advances in Vascular Surgery
Stroke, February 1, 2004; 35(2): 375 - 380.
[Full Text] [PDF]


Home page
StrokeHome page
A. Kay, A. Petzold, M. Kerr, G. Keir, E. Thompson, and J. Nicoll
Temporal Alterations in Cerebrospinal Fluid Amyloid {beta}-Protein and Apolipoprotein E After Subarachnoid Hemorrhage
Stroke, December 1, 2003; 34 (12): e240 - e243.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
N Nathoo, R Chetty, J R van Dellen, and G H Barnett
Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E
Mol. Pathol., June 1, 2003; 56(3): 132 - 136.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Kay, A. Petzold, M. Kerr, G. Keir, E. Thompson, and J. Nicoll
Decreased Cerebrospinal Fluid Apolipoprotein E After Subarachnoid Hemorrhage: Correlation With Injury Severity and Clinical Outcome
Stroke, March 1, 2003; 34(3): 637 - 642.
[Abstract] [Full Text] [PDF]


Home page
Behav ModifHome page
C. K. Haddock, W. S. C. Poston, and J. E. Taylor
Neurocognitive Sequelae Following Coronary Artery Bypass Graft: A Research Agenda for Behavioral Scientists
Behav Modif, January 1, 2003; 27(1): 68 - 82.
[Abstract] [PDF]


Home page
StrokeHome page
C. H.S. Leung, W. S. Poon, L. M. Yu, T. Niskakangas, J. Ohman, M. Niemela, E. Ilveskoski, T. A. Kunnas, and P. J. Karhunen
Is Retrospective Study Reliable in Genetic Studies?
Stroke, October 1, 2001; 32 (10): 2441 - 2441.
[Full Text] [PDF]